Anticonvulsant, Anxiolytic and Antidepressant Properties of the β-caryophyllene in Swiss Mice: Involvement of Benzodiazepine-GABAAergic, Serotonergic and Nitrergic Systems

George    L.   da Silva Oliveira; José    C. Correia L.    da Silva; Ana   P.    dos Santos C. L da Silva; Chistiane    M.   Feitosa; Fernanda    R.   de Castro Almeida

Abstract

Background: Central nervous system disorders such as anxiety, depression and epilepsy are characterized by sharing several molecular mechanisms in common and the involvement of the L-arginine/NO pathway in neurobehavioral studies with β-caryophyllene is still little discussed.

Objectives: One of the objectives of the present study was to demonstrate the anxiolytic behavioral effect of β-caryophyllene (β-CBP) in female Swiss mice, as well as to investigate the molecular mechanisms underlying the results obtained.

Methods: This study evaluated the neurobehavioral effects of β-CBP using the open field test, rota- rod test, elevated plus maze test, novelty suppressed feeding test, tail suspension test and forced swim test, as well as pilocarpine, pentylenetetrazole and isoniazid-induced epileptic seizure models.

Results: The results demonstrated that the neuropharmacological activities of β-CBP may involve benzodiazepine/GABAergic receptors, since the pre-treatment of β-CBP (200 mg/kg) associated with flumazenil (5 mg/kg, benzodiazepine receptor antagonist) and bicuculline (1 mg/kg, selective GABAA receptor antagonist) reestablished the anxiety parameters in the elevated plus-maze test, as well as the results of reduced latency to consume food in the novelty suppressed feeding test. In addition to benzodiazepine/GABAergic receptors, the neuropharmacological properties of β-CBP may be related to inhibition of nitric oxide synthesis, since pre-treatment with L-arginine (500-750 mg/kg) reversed significantly the anxiolytic, antidepressant and anticonvulsant activities of β-CBP.

Conclusion: The results obtained provide additional support in understanding the neuromolecular mechanisms underlying the anxiolytic, antidepressant and anticonvulsive properties of β-CBP in female Swiss mice.

Keywords: β-caryophyllene, benzodiazepine/GABAergic receptors, neurobehavioral effects, neuromolecular mechanisms, nitric oxide, L-arginine/NO pathway.

Graphical Abstract

[1] 
Gertsch, J.; Leonti, M.; Raduner, S.; Racz, I.; Chen, J.Z.; Xie, X.Q.; Altmann, K.H.; Karsak, M.; Zimmer, A. Beta-caryophyllene is a dietary cannabinoid. Proc. Natl. Acad. Sci. USA,  2008, 105(26), 9099-9104.
[http://dx.doi.org/10.1073/pnas.0803601105] [PMID: 18574142] 
[2] 
Buchbauer, G.; Llic, A. Biological Activities of Selected Mono- and Sesquiterpenes: Possible Uses in Medicine.Natural Products: Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes; Ramawat, K.G.; Mérillon, J.M., Eds.; Springer Berlin Heidelberg: Berlin, Heidelberg, 2013, pp. 4109-4159.
[http://dx.doi.org/10.1007/978-3-642-22144-6_183] 
[3] 
Yang, G.; Wu, P.; Zhou, Z.; He, X.; Meng, W.; Zhang, Z. Direct Hydration of β-Caryophyllene. Ind. Eng. Chem. Res.,  2012, 49, 15864-15871.
[http://dx.doi.org/10.1021/ie301294f] 
[4] 
Almeida, T.S.; Rocha, J.B.T.; Rodrigues, F.F.G.; Campos, A.R.; Costa, J.G.M. Chemical composition, antibacterial and antibiotic modulatory effect of Croton campestris essential oils. Ind. Crops Prod.,  2013, 44, 630-633.
[http://dx.doi.org/10.1016/j.indcrop.2012.09.010] 
[5] 
Oliveira, G.L.D.S.; Machado, K.C.; Machado, K.C.; da Silva, A.P.D.S.C.L.; Feitosa, C.M.; de Castro Almeida, F.R. Non-clinical toxicity of β-caryophyllene, a dietary cannabinoid: Absence of adverse effects in female Swiss mice. Regul. Toxicol. Pharmacol.,  2018, 92, 338-346.
[http://dx.doi.org/10.1016/j.yrtph.2017.12.013] [PMID: 29258925] 
[6] 
Segat, G.C.; Manjavachi, M.N.; Matias, D.O.; Passos, G.F.; Freitas, C.S.; Costa, R.; Calixto, J.B. Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice. Neuropharmacology,  2017, 125, 207-219.
[http://dx.doi.org/10.1016/j.neuropharm.2017.07.015] [PMID: 28729222] 
[7] 
Al Mansouri, S.; Ojha, S.; Al Maamari, E.; Al Ameri, M.; Nurulain, S.M.; Bahi, A. The cannabinoid receptor 2 agonist, β-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice. Pharmacol. Biochem. Behav.,  2014, 124, 260-268.
[http://dx.doi.org/10.1016/j.pbb.2014.06.025] [PMID: 24999220] 
[8] 
Kamikubo, R.; Kai, K.; Tsuji-Naito, K.; Akagawa, M. β-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK signaling by activating CB2 receptor in human HepG2 hepatocytes. Mol. Nutr. Food Res.,  2016, 60(10), 2228-2242.
[http://dx.doi.org/10.1002/mnfr.201600197] [PMID: 27234712] 
[9] 
Baldissera, M.D.; Souza, C.F.; Grando, T.H.; Doleski, P.H.; Boligon, A.A.; Stefani, L.M.; Monteiro, S.G. Hypolipidemic effect of β-caryophyllene to treat hyperlipidemic rats. Naunyn Schmiedebergs Arch. Pharmacol.,  2016, 2, 1-9.
[PMID: 27913825] 
[10] 
Fontes, L.B.A.; Dias, D.D.S.; Aarestrup, B.J.V.; Aarestrup, F.M.; Da Silva Filho, A.A.; Corrêa, J.O.D.A. β-Caryophyllene ameliorates the development of experimental autoimmune encephalomyelitis in C57BL/6 mice. Biomed. Pharmacother.,  2017, 91, 257-264.
[http://dx.doi.org/10.1016/j.biopha.2017.04.092] [PMID: 28463791] 
[11] 
Basha, R.H.; Sankaranarayanan, C. β-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats. Chem. Biol. Interact.,  2016, 245, 50-58.
[http://dx.doi.org/10.1016/j.cbi.2015.12.019] [PMID: 26748309] 
[12] 
Hu, Y.; Zeng, Z.; Wang, B.; Guo, S. Trans-caryophyllene inhibits amyloid β (Aβ) oligomer-induced neuroinflammation in BV-2 microglial cells. Int. Immunopharmacol.,  2017, 51, 91-98.
[http://dx.doi.org/10.1016/j.intimp.2017.07.009] [PMID: 28821008] 
[13] 
Bahi, A.; Al Mansouri, S.; Al Memari, E.; Al Ameri, M.; Nurulain, S.M.; Ojha, S. β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. Physiol. Behav.,  2014, 135, 119-124.
[http://dx.doi.org/10.1016/j.physbeh.2014.06.003] [PMID: 24930711] 
[14] 
Hwang, E.S.; Kim, H.B.; Lee, S.; Kim, M.J.; Kim, K.J.; Han, G.; Han, S.Y.; Lee, E.A.; Yoon, J.H.; Kim, D.O.; Maeng, S.; Park, J.H. Antidepressant-like effects of β-caryophyllene on restraint plus stress-induced depression. Behav. Brain Res.,  2020, 380112439
[http://dx.doi.org/10.1016/j.bbr.2019.112439] [PMID: 31862467] 
[15] 
Assis, L.C.; Straliotto, M.R.; Engel, D.; Hort, M.A.; Dutra, R.C.; de Bem, A.F. β-Caryophyllene protects the C6 glioma cells against glutamate-induced excitotoxicity through the Nrf2 pathway. Neuroscience,  2014, 279, 220-231.
[http://dx.doi.org/10.1016/j.neuroscience.2014.08.043] [PMID: 25194788] 
[16] 
de Oliveira, C.C.; de Oliveira, C.V.; Grigoletto, J.; Ribeiro, L.R.; Funck, V.R.; Grauncke, A.C.B.; de Souza, T.L.; Souto, N.S.; Furian, A.F.; Menezes, I.R.; Oliveira, M.S. Anticonvulsant activity of β-caryophyllene against pentylenetetrazol-induced seizures. Epilepsy Behav.,  2016, 56, 26-31.
[http://dx.doi.org/10.1016/j.yebeh.2015.12.040] [PMID: 26827298] 
[17] 
Cheng, Y.; Dong, Z.; Liu, S. β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway. Pharmacology,  2014, 94(1-2), 1-12.
[http://dx.doi.org/10.1159/000362689] [PMID: 25171128] 
[18] 
Ojha, S.; Javed, H.; Azimullah, S.; Haque, M.E. β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease. Mol. Cell. Biochem.,  2016, 418(1-2), 59-70.
[http://dx.doi.org/10.1007/s11010-016-2733-y] [PMID: 27316720] 
[19] 
Bruenig, D.; Morris, C.P.; Mehta, D.; Harvey, W.; Lawford, B.; Young, R.M.; Voisey, J. Nitric oxide pathway genes (NOS1AP and NOS1) are involved in PTSD severity, depression, anxiety, stress and resilience. Gene,  2017, 625, 42-48.
[http://dx.doi.org/10.1016/j.gene.2017.04.048] [PMID: 28465168] 
[20] 
Sarginson, J.E.; Deakin, J.F.W.; Anderson, I.M.; Downey, D.; Thomas, E.; Elliott, R.; Juhasz, G. Neuronal nitric oxide synthase (NOS1) polymorphisms interact with financial hardship to affect depression risk. Neuropsychopharmacology,  2014, 39(12), 2857-2866.
[http://dx.doi.org/10.1038/npp.2014.137] [PMID: 24917196] 
[21] 
Möhler, H. The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology,  2012, 62(1), 42-53.
[http://dx.doi.org/10.1016/j.neuropharm.2011.08.040] [PMID: 21889518] 
[22] 
Żmudzka, E.; Sałaciak, K.; Sapa, J.; Pytka, K. Serotonin receptors in depression and anxiety: Insights from animal studies. Life Sci.,  2018, 210, 106-124.
[http://dx.doi.org/10.1016/j.lfs.2018.08.050] [PMID: 30144453] 
[23] 
Machado, K.C.; Oliveira, G.L.S.; Machado, K.C.; Islam, M.T.; Junior, A.L.G.; De Sousa, D.P.; Freitas, R.M. Anticonvulsant and behavioral effects observed in mice following treatment with an ester derivative of ferulic acid: Isopentyl ferulate. Chem. Biol. Interact.,  2015, 242, 273-279.
[http://dx.doi.org/10.1016/j.cbi.2015.10.003] [PMID: 26456888] 
[24] 
Deacon, R.M.J. Digging and marble burying in mice: simple methods for in vivo identification of biological impacts. Nat. Protoc.,  2006, 1(1), 122-124.
[http://dx.doi.org/10.1038/nprot.2006.20] [PMID: 17406223] 
[25] 
Onaivi, E.S.; Green, M.R.; Martin, B.R. Pharmacological characterization of cannabinoids in the elevated plus maze. J. Pharmacol. Exp. Ther.,  1990, 253(3), 1002-1009.
[PMID: 2162942] 
[26] 
Santarelli, L.; Saxe, M.; Gross, C.; Surget, A.; Battaglia, F.; Dulawa, S.; Weisstaub, N.; Lee, J.; Duman, R.; Arancio, O.; Belzung, C.; Hen, R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science,  2003, 301(5634), 805-809.
[http://dx.doi.org/10.1126/science.1083328] [PMID: 12907793] 
[27] 
Steru, L.; Chermat, R.; Thierry, B.; Mico, J.A.; Lenegre, A.; Steru, M.; Simon, P.; Porsolt, R.D. The automated Tail Suspension Test: a computerized device which differentiates psychotropic drugs. Prog. Neuropsychopharmacol. Biol. Psychiatry,  1987, 11(6), 659-671.
[http://dx.doi.org/10.1016/0278-5846(87)90002-9] [PMID: 2894041] 
[28] 
Porsolt, R.D.; Anton, G.; Blavet, N.; Jalfre, M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol.,  1978, 47(4), 379-391.
[http://dx.doi.org/10.1016/0014-2999(78)90118-8] [PMID: 204499] 
[29] 
Ducottet, C.; Belzung, C. Behaviour in the elevated plus-maze predicts coping after subchronic mild stress in mice. Physiol. Behav.,  2004, 81(3), 417-426.
[http://dx.doi.org/10.1016/j.physbeh.2004.01.013] [PMID: 15135013] 
[30] 
Galdino, P.M.; Nascimento, M.V.M.; Florentino, I.F.; Lino, R.C.; Fajemiroye, J.O.; Chaibub, B.A.; de Paula, J.R.; de Lima, T.C.; Costa, E.A. The anxiolytic-like effect of an essential oil derived from Spiranthera odoratissima A. St. Hil. leaves and its major component, β-caryophyllene, in male mice. Prog. Neuropsychopharmacol. Biol. Psychiatry,  2012, 38(2), 276-284.
[http://dx.doi.org/10.1016/j.pnpbp.2012.04.012] [PMID: 22542869] 
[31] 
Paré, W.P. Hyponeophagia in Wistar Kyoto (WKY) rats. Physiol. Behav.,  1994, 55(5), 975-978.
[http://dx.doi.org/10.1016/0031-9384(94)90090-6] [PMID: 8022922] 
[32] 
Simon, P.; Dupuis, R.; Costentin, J. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav. Brain Res.,  1994, 61(1), 59-64.
[http://dx.doi.org/10.1016/0166-4328(94)90008-6] [PMID: 7913324] 
[33] 
Treit, D.; Fundytus, M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol. Biochem. Behav.,  1988, 31(4), 959-962.
[http://dx.doi.org/10.1016/0091-3057(88)90413-3] [PMID: 3252289] 
[34] 
American Psychiatric Association (APS). Diagnostic and Statistical Manual of Mental Disorders, 2013.
[35] 
Auvin, S.; NEHLIG, A. Models of Seizures and Status Epilepticus Early in Life A2 - Pitkänen, Asla. In:Models of Seizures and Epilepsy (Second edition). ; Buckmaster, P. S., Ed.; Academic Press, , 2017, pp. 569-586.

[36] 
Liu, H.; Song, Z.; Liao, D.; Zhang, T.; Liu, F.; Zhuang, K.; Luo, K.; Yang, L. Neuroprotective effects of trans-caryophyllene against kainic acid induced seizure activity and oxidative stress in mice. Neurochem. Res.,  2015, 40(1), 118-123.
[http://dx.doi.org/10.1007/s11064-014-1474-0] [PMID: 25417010] 
[37] 
Wongsamitkul, N.; Maldifassi, M.C.; Simeone, X.; Baur, R.; Ernst, M.; Sigel, E. α subunits in GABAA receptors are dispensable for GABA and diazepam action. Sci. Rep.,  2017, 7(1), 15498.
[http://dx.doi.org/10.1038/s41598-017-15628-7] [PMID: 29138471] 
[38] 
Smart, T.G.; Stephenson, F.A. A half century of γ-aminobutyric acid. Brain Neurosci. Adv.,  2019, 32398212819858249
[http://dx.doi.org/10.1177/2398212819858249] [PMID: 32166183] 
[39] 
Cryan, J.F.; Slattery, D.A. GABAB Receptors and Depression: Current Status. In: Advances in Pharmacology; Blackburn, T. P, Ed.; Academic Press, 2010, 58, pp. 427-451.
[40] 
Olsen, R.W. GABAA receptor: Positive and negative allosteric modulators. Neuropharmacology,  2018, 136(Pt A), 10-22.
[http://dx.doi.org/10.1016/j.neuropharm.2018.01.036] [PMID: 29407219] 
[41] 
Kessler, A.; Sahin-Nadeem, H.; Lummis, S.C.; Weigel, I.; Pischetsrieder, M.; Buettner, A.; Villmann, C. GABA(A) receptor modulation by terpenoids from Sideritis extracts. Mol. Nutr. Food Res.,  2014, 58(4), 851-862.
[http://dx.doi.org/10.1002/mnfr.201300420] [PMID: 24273211] 
[42] 
Bento, A.F.; Marcon, R.; Dutra, R.C.; Claudino, R.F.; Cola, M.; Leite, D.F.; Calixto, J.B. β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway. Am. J. Pathol.,  2011, 178(3), 1153-1166.
[http://dx.doi.org/10.1016/j.ajpath.2010.11.052] [PMID: 21356367] 
[43] 
García, M.C.; Cinquina, V.; Palomo-Garo, C.; Rábano, A.; Fernández-Ruiz, J. Identification of CB₂ receptors in human nigral neurons that degenerate in Parkinson’s disease. Neurosci. Lett.,  2015, 587, 1-4.
[http://dx.doi.org/10.1016/j.neulet.2014.12.003] [PMID: 25481767] 
[44] 
Javed, H.; Azimullah, S.; Haque, M.E.; Ojha, S.K. Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson’s Disease. Front. Neurosci.,  2016, 10, 321.
[http://dx.doi.org/10.3389/fnins.2016.00321] [PMID: 27531971] 
[45] 
Sieghart, W. Chapter Three - Allosteric Modulation of GABAA Receptors via Multiple Drug-Binding Sites. In: Advances in Pharmacology; Rudolph, U., Ed.; Academic Press, 2015, 72, pp. 53-96.
[46] 
Zhang, H.Y.; Gao, M.; Liu, Q.R.; Bi, G.H.; Li, X.; Yang, H.J.; Gardner, E.L.; Wu, J.; Xi, Z.X. Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice. Proc. Natl. Acad. Sci. USA,  2014, 111(46), E5007-E5015.
[http://dx.doi.org/10.1073/pnas.1413210111] [PMID: 25368177] 
[47] 
Wallace, M.J.; Martin, B.R.; DeLorenzo, R.J. Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur. J. Pharmacol.,  2002, 452(3), 295-301.
[http://dx.doi.org/10.1016/S0014-2999(02)02331-2] [PMID: 12359270] 
[48] 
Wallace, M.J.; Blair, R.E.; Falenski, K.W.; Martin, B.R.; DeLorenzo, R.J. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J. Pharmacol. Exp. Ther.,  2003, 307(1), 129-137.
[http://dx.doi.org/10.1124/jpet.103.051920] [PMID: 12954810] 
[49] 
Ramirez-Mahaluf, J.P.; Compte, A. Serotonergic Modulation of Cognition in Prefrontal Cortical Circuits in Major Depression A2 - Anticevic, Alan.Computational Psychiatry; Murray, J.D., Ed.; Academic Press, 2018, pp. 27-46.
[http://dx.doi.org/10.1016/B978-0-12-809825-7.00002-X] 
[50] 
de Oliveira, D.R.; da Silva, D.M.; Florentino, I.F.; de Brito, A.F.; Fajemiroye, J.O.; da Silva, D.P.B.; da Rocha, F.F.; Costa, E.A.; Galdino, P.M. Monoamine Involvement in the Antidepressant-Like Effect of β-Caryophyllene. CNS Neurol. Disord. Drug Targets,  2018, 17(4), 309-320.
[http://dx.doi.org/10.2174/1871527317666180420150249] [PMID: 29676236] 
[51] 
Gonçalves, A.E.; Bürger, C.; Amoah, S.K.S.; Tolardo, R.; Biavatti, M.W.; de Souza, M.M. The antidepressant-like effect of Hedyosmum brasiliense and its sesquiterpene lactone, podoandin in mice: evidence for the involvement of adrenergic, dopaminergic and serotonergic systems. Eur. J. Pharmacol.,  2012, 674(2-3), 307-314.
[http://dx.doi.org/10.1016/j.ejphar.2011.11.009] [PMID: 22115892] 
[52] 
Hu, Y.; Zhu, D.Y. Chapter Six - Hippocampus and Nitric Oxide. In: Litwack, G. Vitamins & Hormones; Academic Press, 2014, 96, pp. 127-160.
[53] 
Chang, H.J.; Kim, J.M.; Lee, J.C.; Kim, W.K.; Chun, H.S. Protective effect of β-caryophyllene, a natural bicyclic sesquiterpene, against cerebral ischemic injury. J. Med. Food,  2013, 16(6), 471-480.
[http://dx.doi.org/10.1089/jmf.2012.2283] [PMID: 23734999] 
[54] 
Chen, B.; Choi, H.; Hirsch, L.J.; Katz, A.; Legge, A.; Buchsbaum, R.; Detyniecki, K. Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy. Epilepsy Behav.,  2017, 76, 24-31.
[http://dx.doi.org/10.1016/j.yebeh.2017.08.039] [PMID: 28931473] 
[55] 
Sartori, S.B.; Singewald, N. Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacol. Ther.,  2019, 204107402
[http://dx.doi.org/10.1016/j.pharmthera.2019.107402] [PMID: 31470029] 
[56] 
Sharma, C.; Al Kaabi, J.M.; Nurulain, S.M.; Goyal, S.N.; Kamal, M.A.; Ojha, S. Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise. Curr. Pharm. Des.,  2016, 22(21), 3237-3264.
[http://dx.doi.org/10.2174/1381612822666160311115226] [PMID: 26965491] 
[57] 
Schmitt, D.; Levy, R.; Carroll, B. Toxicological Evaluation of β-Caryophyllene Oil: Subchronic Toxicity in Rats. Int. J. Toxicol.,  2016, 35(5), 558-567.
[http://dx.doi.org/10.1177/1091581816655303] [PMID: 27358239] 
[58] 
Bastaki, M.; Api, A.M.; Aubanel, M.; Bauter, M.; Cachet, T.; Demyttenaere, J.C.R.; Diop, M.M.; Harman, C.L.; Hayashi, S.M.; Krammer, G.; Lu, V.; Marone, P.A.; Mendes, O.; Renskers, K.J.; Schnabel, J.; Tsang, S.Y.; Taylor, S.V. Dietary administration of β-caryophyllene and its epoxide to Sprague-Dawley rats for 90 days. Food Chem. Toxicol.,  2020, 135110876
[http://dx.doi.org/10.1016/j.fct.2019.110876] [PMID: 31610257] 
[59] 
Tian, X.; Peng, J.; Zhong, J.; Yang, M.; Pang, J.; Lou, J.; Li, M.; An, R.; Zhang, Q.; Xu, L.; Dong, Z. β-Caryophyllene protects in vitro neurovascular unit against oxygen-glucose deprivation and re-oxygenation-induced injury. J. Neurochem.,  2016, 139(5), 757-768.
[http://dx.doi.org/10.1111/jnc.13833] [PMID: 27565895] 

Rights & Permissions Print Cite

Article Metrics

79

1

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

For Visitors

DOI https://dx.doi.org/10.2174/1874467213666200510004622	Print ISSN 1874-4672
Publisher Name Bentham Science Publisher	Online ISSN 1874-4702

Current Molecular Pharmacology

Anticonvulsant, Anxiolytic and Antidepressant Properties of the β-caryophyllene in Swiss Mice: Involvement of Benzodiazepine-GABAAergic, Serotonergic and Nitrergic Systems

Abstract

Graphical Abstract

Related Journals

Related Books

Related Articles